I SEP has a total of 15 patent applications. It increased the IP activity by 450.0%. Its first patent ever was published in 2017. It filed its patents most often in France, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets medical technology are SANDSDALEN CHRISTIAN, VADUS INC and MUEFA AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology |
# | Technology | |
---|---|---|
#1 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Picot Sylvain | 14 |
#2 | Gadrat Francis | 14 |
#3 | Forest-Villegas Patricia | 14 |
#4 | Chollet Stéphane | 9 |
#5 | Chollet Stephane | 5 |
#6 | Decouture Benoît | 2 |
#7 | Francis Gadrat | 1 |
#8 | Stéphane Chollet | 1 |
#9 | Sylvain Picot | 1 |
#10 | Patricia Forest-Villegas | 1 |
Publication | Filing date | Title |
---|---|---|
FR3097770A1 | System and method for treating hemorrhagic fluid for autotransfusion | |
BR112020013045A2 | system and method of treating hemorrhagic fluid for autotransfusion |